Ubisoft has just revealed the maps for Tom Clancy’s Ghost Recon Wildlands. The upcoming game is now also open for beta testing!
The upcoming open world tactical shooter is the latest in the Ghost Recon series. This would also be the first Ghost Recon game to have an open world environment. The setting of the game would also return to modern times, just like in the very first game.
Tom Clancy’s Ghost Recon Wildlands Release Date
The game would be released exactly on March 7, 2017. The latest Ghost Recon would also be available for the PC, PlayStation 4, and Xbox One. A delay would also least likely happen, since the game is already open for beta testing and is looking for beta testers right now!
Ghost Recon Wildlands Beta Test Wanted
Why wait until March next year if you could be a beta tester for the game? Ubisoft has now set up a registration for beta testers. Beta testers would take part in the Operation Kingslayer mission. It is set in the jungles of Bolivia, with lush forests, cold mountains, and salt flats. The main mission of beta testers would be to eliminate the Santa Blanca Drug Cartel with the most action packed way possible. To do so, beta testers would be given access to a huge arsenal of weapons to blow up the cartel to bits.
The data that beta testers would collect is valuable to the developers of the game. This is to ensure that the game would be almost totally bug free by the time of release. Players could sign up for the beta test in the official Ubisoft website right here.
Ghost Recon Wildlands Map revealed!
Sure, the game takes place in a fictional rendition of Bolivia. But just because it is taking place in one location doesn’t mean the area would be small. Ubisoft claims the upcoming Ghost Recon to have one of the largest environments to explore in an open world game, and Ubisoft has evidence to back up their claims. The map includes 21 different regions, and each one even has cities and such within.
None Playing Characters in Tom Clancy’s Ghost Recon Wildlands would also have realistic behavior.